Innovation & intellectual property · 29/09/2022Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Treosulfan Patent
Summary
The U.S. Patent and Trademark Office has issued an order granting a one-year extension to the term of U.S. Patent No. 7,199,162, covering Treosulfan, a medication used in cancer treatment.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →